Latest filing published 18 Mar 2024 for Karuna Therapeutics, Inc., €300k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Jeffrey M. Jonas span 2 companies, the busiest being Sage Therapeutics, Inc. and Karuna Therapeutics, Inc. In total, 15 filings cover trades dated from 31 December 2015 to 18 March 2024.
No open-market sale appears; the market trades are 1 purchase. No amount is published for 1 filing, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 5 share grants and 8 option exercises.
The newest entry dates from 18 March 2024: a transaction of €300k, in Karuna Therapeutics, Inc. The latest purchase dates back some time: it was published 3,937 days ago, on 7 January 2016. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations